SYTE.bio

SYTE.bio is a leading clinical-stage synthetic biology company specializing in DNA and RNA-based vaccines and gene therapies.

Our advanced proprietary platforms are designed for safety, stability, and efficacy, offering non-viral solutions that redefine treatment possibilities for severe medical conditions.

By harnessing cutting-edge biotechnology, we enhance therapeutic delivery, molecular stability, and immune response while minimizing risks associated with traditional approaches.

We are committed to delivering groundbreaking solutions that improve lives and shape the future of medicine.

Mission

Our mission is to lead a global transformation in medicine by leveraging innovative synthetic biology platforms to deliver safe, effective, and non-viral DNA and RNA-based therapeutics and vaccines. We aim to address urgent medical challenges and provide solutions for diseases with unmet clinical needs, ensuring accessibility and affordability for patients worldwide.

Vision

We envision a future where advanced synthetic biology enables precise, personalized, and preventative medicine for all. SYTE.bio strives to be a world leader in the development and commercialization of next-generation nucleic acid-based therapies and vaccines, shaping the future of healthcare and empowering communities to live healthier, longer lives.

Values

Collaboration

We believe in fostering strong partnerships with researchers, healthcare providers, and communities to drive collective progress.

We design scalable and cost-effective solutions that promote global accessibility and environmental sustainability.

Everything we do revolves around improving the lives of patients, offering accessible, precise, and transformative therapies.

We embrace cutting-edge science and technology to pioneer breakthroughs in synthetic biology and nucleic acid therapeutics.

We are committed to delivering safe, non-viral solutions while maintaining the highest ethical and scientific standards in all our endeavors.

Leadership

Martin Williams

CEO & Founder

Mariano Belaich

CSO & Co-Founder

Juan Pablo Tevini

 Legals

Augusto Tevini

 Finances

Carolina Alarco

Senior Biotech Executive